Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features
RNA-seq (gene expression) · human · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 15 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome featuresActa pharmaceutica Sinica. B · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE252529_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1061122 and SRA study SRP481460. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 6 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8002601 A549_DMSO_Rep1 A549_DMSO
- GSM8002602 A549_DMSO_Rep2 A549_DMSO
- GSM8002603 A549_DMSO_Rep3 A549_DMSO
- GSM8002604 A549_Triptolide_Rep1 A549_Triptolide
- GSM8002605 A549_Triptolide_Rep2 A549_Triptolide
- GSM8002606 HepG2_DMSO_Rep1 HepG2_DMSO
- GSM8002607 HepG2_DMSO_Rep2 HepG2_DMSO
- GSM8002608 HepG2_DMSO_Rep3 HepG2_DMSO
- GSM8002609 HepG2_Triptolide_Rep1 HepG2_Triptolide
- GSM8002610 HepG2_Triptolide_Rep2 HepG2_Triptolide
- GSM8002611 HT29_DMSO_Rep1 HT29_DMSO
- GSM8002612 HT29_DMSO_Rep2 HT29_DMSO
- GSM8002613 HT29_DMSO_Rep3 HT29_DMSO
- GSM8002614 HT29_Cyclosporine_Rep1 HT29_Cyclosporine
- GSM8002615 HT29_Cyclosporine_Rep2 HT29_Cyclosporine
- GSE279542 Open Chromatin Guided Interpretable Machine Learning Reveals Cancer-Specific Chromatin Features in Cell-free DNA 20 samples shares interpretable, learning, features, machine
- GSE296948 Application of machine learning (ML) / deep learning (DL) using multiple epigenetic features reveals H3K27Ac as driver of gene expression prediction across patients with glioblastoma 11 samples shares prediction, learning, features, machine
- GSE296944 Application of machine learning (ML) / deep learning (DL) using multiple epigenetic features reveals H3K27Ac as driver of gene expression prediction across patients with glioblastoma [ChIP-Seq] 7 samples shares prediction, learning, features, machine
- GSE289786 Improved Prediction of Venetoclax and Azacitidine Efficacy in Acute Myeloid Leukemia through Machine Learning [AML patients] 142 samples shares prediction, learning, machine
- GSE288490 SLIDE analysis of the scRNA-seq data using an interpretable factor-analysis machine learning framework, that moves beyond predictive biomarkers to try and infer latent factors underlying LS pathophysiology. 16 samples shares interpretable, learning, machine
- GSE289785 Improved Prediction of Venetoclax and Azacitidine Efficacy in Acute Myeloid Leukemia through Machine Learning 12 samples shares prediction, learning, machine
- GSE293316 Deep Learning Models for Cell Cycle Phase Prediction from Single-Cell RNA Sequencing Data 10 samples shares prediction, learning
- GSE49711 RNA-Seq reveals an unprecedented complexity of the neuroblastoma transcriptome and is suitable for clinical endpoint prediction [RNA-Seq] 498 samples shares prediction
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.